Recombinant Bevacizumab anticorps (Biotin)

N° du produit ABIN7488554

Détail du produit anti-Bevacizumab anticorps (Biotin)

Antigène: Bevacizumab

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Bevacizumab est conjugé à/à la Biotin

Fonction: Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)

Attributs du produit: Anti-idiotypic Antibodies

Immunogène: Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.

Clone: AY13

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Stock: -20 °C

Détails sur Bevacizumab

Antigène: Bevacizumab

Abstract: Bevacizumab Produits

Classe de substances: Antibody

Sujet: A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.